Federal contract award
75N95023F00001
PHASE I COCAINE DRUG INTERACTION STUDY. TO6. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 08/10/2023 - 02/09/2025. NIDA REF. NO. N01DA-19-8947.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | 75N95019D00009 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $269.7K |
| Current contract value | $269.7K |
| Potential contract value / ceiling | $269.7K |
| Start date | Aug 10, 2023 |
| Current end date | Oct 31, 2025 |
| Potential end date | Oct 31, 2025 |
| Latest award activity | Sep 2, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 2, 2025 | P00004 | $0 | PHASE I COCAINE DRUG INTERACTION STUDY. TO6. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 08/10/2023 - 10/31/2025. NIDA REF. NO. N01DA-19-8947. NO COST EXTENSION. |
| May 29, 2025 | P00003 | $0 | PHASE I COCAINE DRUG INTERACTION STUDY. TO6. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 08/10/2023 - 08/31/2025. NIDA REF. NO. N01DA-19-8947. NO COST EXTENSION. |
| Feb 7, 2025 | P00002 | $0 | PHASE I COCAINE DRUG INTERACTION STUDY. TO6. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 08/10/2023 - 05/31/2025. NIDA REF. NO. N01DA-19-8947. CHANGE ORDER MODIFICATION. |
| Aug 19, 2024 | P00001 | $67.3K | PHASE I COCAINE DRUG INTERACTION STUDY. TO6. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 08/10/2023 - 02/09/2025. NIDA REF. NO. N01DA-19-8947. CHANGE ORDER MODIFICATION. |
| Aug 10, 2023 | 0 | $202.3K | PHASE I COCAINE DRUG INTERACTION STUDY. TO6. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 08/10/2023 - 02/09/2025. NIDA REF. NO. N01DA-19-8947. |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Josh Lazarus | Contact | josh.lazarus@nih.gov 3018276923 | Source | Aug 22, 2023 |
| Josh Lazarus | Contact | josh.lazarus@nih.gov 3018276923 | Source | Aug 22, 2023 |
| Josh Lazarus | Contact | josh.lazarus@nih.gov 3018276923 | Source | Aug 3, 2023 |
| Josh Lazarus | Contact | josh.lazarus@nih.gov 3018276923 | Source | Jul 31, 2023 |
| Josh Lazarus | Contact | josh.lazarus@nih.gov 3018276923 | Source | Jul 19, 2023 |
| Josh Lazarus | Contact | josh.lazarus@nih.gov 3018276923 | Source | Jun 12, 2023 |
| Josh Lazarus | Contact | josh.lazarus@nih.gov 3018276923 | Source | Jun 12, 2023 |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.